1. Resnick D, Shaul SR, Robins JM. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extraspinal manifestations. Radiology 1975 115:513-24.
3. Schlapbach P, Beyeler C, Gerber NJ, et al. Diffuse idiopathic skeletal hyperostosis (DISH) of the spine: a cause of back pain? A controlled study. Br J Rheumatol 1989 28:299-303.
4. Aydin E, Akdogan V, Akkuzu B, et al. Six cases of Forestier syndrome, a rare cause of dysphagia. Acta Otolaryngol 2006 126:775-8.
5. Okada E, Yoshii T, Yamada T, et al. Spinal fractures in patients with Diffuse idiopathic skeletal hyperostosis: a nationwide multi-institution survey. J Orthop Sci 2019 24:601-6.
6. Okada E, Shimizu K, Kato M, et al. Spinal fractures in patients with diffuse idiopathic skeletal hyperostosis: clinical characteristics by fracture level. J Orthop Sci 2019 24:393-9.
7. Okada E, Tsuji T, Shimizu K, et al. CT-based morphological analysis of spinal fractures in patients with diffuse idiopathic skeletal hyperostosis. J Orthop Sci 2017 22:3-9.
8. Okada E, Yagi M, Fujita N, et al. Lumbar spinal canal stenosis in patients with diffuse idiopathic skeletal hyperostosis: Surgical outcomes after posterior decompression surgery without spinal instrumentation. J Orthop Sci 2019 24:999-1004.
9. Otsuki B, Fujibayashi S, Takemoto M, et al. Diffuse idiopathic skeletal hyperostosis (DISH) is a risk factor for further surgery in short-segment lumbar interbody fusion. Eur Spine J 2015 24:2514-9.
10. Yamada K, Satoh S, Abe Y, et al. Diffuse idiopathic skeletal hyperostosis extended to the lumbar segment is a risk factor of reoperation in patients treated surgically for lumbar stenosis. Spine (Phila Pa 1976) 2018 43:1446-53.
11. Westerveld LA, van Ufford HM, Verlaan JJ, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in an outpatient population in The Netherlands. J Rheumatol 2008 35:1635-8.
12. Kagotani R, Yoshida M, Muraki S, et al. Prevalence of diffuse idiopathic skeletal hyperostosis (DISH) of the whole spine and its association with lumbar spondylosis and knee osteoarthritis: the ROAD study. J Bone Miner Metab 2015 33:221-9.
13. Weinfeld RM, Olson PN, Maki DD, et al. The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiol 1997 26:222-5.
14. Gerber LH, Helfgott RK, Gross EG, et al. Vertebral abnormalities associated with synthetic retinoid use. J Am Acad Dermatol 1984 10(5 Pt 1):817-23.
15. Kim SK, Choi BR, Kim CG, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in Korea. J Rheumatol 2004 31:2032-5.
16. Sukahara S, Miyazawa N, Akagawa H, et al. COL6A1, the candidate gene for ossification of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal hyperostosis in Japanese. Spine (Phila Pa 1976) 2005 30:2321-4.
17. Mader R, Novofestovski I, Adawi M, et al. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Semin Arthritis Rheum 2009 38:361-5.
18. Sencan D, Elden H, Nacitarhan V, et al. The prevalence of diffuse idiopathic skeletal hyperostosis in patients with diabetes mellitus. Rheumatol Int 2005 25:518-21.
19. Vezyroglou G, Mitropoulos A, Antoniadis C. A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. J Rheumatol 1996 2:672-6.
20. Julkunen H, Aromaa A, Knekt P. Diffuse idiopathic skeletal hyperostosis (DISH) and spondylosis deformans as predictors of cardiovascular diseases and cancer. Scand J Rheumatol 1981 10:241-8.
21. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005 365:1415-28.
22. Alexander CM, Landsman PB, Teutsch SM, et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003 52:1210-4.
23. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 2004 27:2444-9.
24. Fujita N, Ishihara S, Michikawa T, et al. Potential association of metabolic and musculoskeletal disorders with lumbar intervertebral disc degeneration: cross-sectional study using medical checkup data. J Orthop Sci 2020 25:384-8.
25. Ishihara S, Fujita N, Azuma K, et al. Spinal epidural lipomatosis is a previously unrecognized manifestation of metabolic syndrome. Spine J 2019 19:493-500.
26. Fujita N, Hosogane N, Hikata T, et al. Potential involvement of obesity-associated chronic inflammation in the pathogenesis of idiopathic spinal epidural lipomatosis. Spine (Phila Pa 1976) 2016 41:E1402-7.
27. Definition and the diagnostic standard for metabolic syndrome--Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nihon Naika Gakkai Zasshi 2005 94:794-809.
29. Banno T, Togawa D, Hasegawa T, et al. The controlled study of diffuse idiopathic skeletal hyperostosis for the assessment of physical function in elderly populations. J Orthop Sci 2018 23:929-34.
30. Chaput CD, Siddiqui M, Rahm MD. Obesity and calcification of the ligaments of the spine: a comprehensive CT analysis of the entire spine in a random trauma population. Spine J 2019 19:1346-53.
31. Mader R, Lavi I. Diabetes mellitus and hypertension as risk factors for early diffuse idiopathic skeletal hyperostosis (DISH). Ost eoarthritis Cartilage 2009 17:825-8.
32. Dan Lantsman C, Herman A, Verlaan JJ, et al. Abdominal fat distribution in diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis patients compared to controls. Clin Radiol 2018 73:910.e15-910.e20.
33. Rogers J, Waldron T. DISH and the monastic way of life. Int J Osteoarchaeol 2001 11:357-65.
34. Theyskens NC, Paulino Pereira NR, Janssen SJ, et al. The prevalence of spinal epidural lipomatosis on magnetic resonance imaging. Spine J 2017 17:969-76.